EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
|
EQS-Ad-hoc: SYNLAB AG / Key word(s): Personnel
SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
15-March-2023 / 18:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
Munich, 15 March 2023 – The Supervisory Board of SYNLAB AG (SYNLAB, FSE: SYAB) today announces that the appointment of Mathieu Floreani as Chief Executive Officer (CEO) of the SYNLAB Group has been extended until the end of 30 April 2028 and the appointment of Sami Badarani as Chief Financial Officer (CFO) of the SYNLAB Group has been extended until the end of 30 April 2026.
15-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
SYNLAB AG |
|
Moosacher Straße 88 |
|
80809 Munich |
|
Germany |
| Phone: |
+49 1701183753 |
| E-mail: |
[email protected] |
| Internet: |
www.synlab.com/ |
| ISIN: |
DE000A2TSL71 |
| WKN: |
A2TSL7 |
| Indices: |
SDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1583627 |
| |
| End of Announcement |
EQS News Service |
1583627 15-March-2023 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Umsatzerlöse1 |
0,00 |
1.807,90 |
1.906,10 |
2.621,20 |
3.764,92 |
3.250,52 |
2.635,16 |
| EBITDA1,2 |
0,00 |
382,90 |
397,40 |
679,20 |
1.179,89 |
532,98 |
353,28 |
| EBITDA-Marge3 |
0,00 |
21,18 |
20,85 |
25,91 |
31,34 |
16,40 |
|
| EBIT1,4 |
0,00 |
138,80 |
71,90 |
315,50 |
914,53 |
231,68 |
59,16 |
| EBIT-Marge5 |
0,00 |
7,68 |
3,77 |
12,04 |
24,29 |
7,13 |
2,25 |
| Jahresüberschuss1 |
0,00 |
-42,10 |
-108,00 |
259,10 |
627,54 |
152,52 |
92,96 |
| Netto-Marge6 |
0,00 |
-2,33 |
-5,67 |
9,88 |
16,67 |
4,69 |
3,53 |
| Cashflow1,7 |
0,00 |
120,30 |
238,60 |
904,70 |
1.011,70 |
629,63 |
363,13 |
| Ergebnis je Aktie8 |
0,00 |
-0,19 |
-0,49 |
1,16 |
2,82 |
0,68 |
0,42 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,33 |
0,33 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Deloitte
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Synlab |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A2TSL7 |
11,460 |
|
2.546,67 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 17,63 |
21,74 |
0,81 |
16,95 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 1,09 |
7,01 |
0,97 |
9,20 |
| Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23
in % |
Hauptversammlung |
| 0,33 |
0,00 |
0,00 |
17.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 08.05.2024 |
08.08.2024 |
07.11.2024 |
25.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 3,17% |
4,04% |
0,70% |
6,31% |
|
|
SYNLAB AG DE000A2TSL71